肥胖、代谢综合征与青光眼在All of Us研究中的关联
该研究纳入156 362名40岁以上个体,分析体重指数(BMI)、中心性肥胖、腰围、代谢综合征(MetS)及代谢综合征严重程度评分(MSSS)与青光眼患病率的关联。结果显示较高BMI和腰围与青光眼 odds 降低相关,而MetS及较高MSSS与青光眼 odds 升高相关。
要点
- 超重和肥胖(基于BMI)与青光眼 odds 降低相关。
- 中心性肥胖和腰围增加与青光眼 odds 降低相关。
- 代谢综合征及较高MSSS与青光眼 odds 升高相关。
核心结论
- 在All of Us项目中,较高BMI和腰围增加与青光眼可能性降低相关,而代谢综合征与青光眼可能性增加相关。
研究设计与样本
- 研究纳入156 362名年龄超过40岁的个体,采用逻辑回归模型分析肥胖、代谢综合征与青光眼患病率的关联。
主要发现
- 基于BMI的超重个体相比非超重个体青光眼OR为0.80(95%CI 0.74至0.86),肥胖个体OR为0.79(95%CI 0.74至0.85)。
- 中心性肥胖个体青光眼OR为0.87(95%CI 0.83至0.93),腰围增加个体OR为0.97(95%CI 0.95至0.99)。
- 代谢综合征个体相比无代谢综合征个体青光眼OR为1.35(95%CI 1.27至1.44),MSSS每增加单位OR为1.19(95%CI 1.16至1.22)。
关键数值与推荐
- 肥胖由体重指数(BMI)和基于腰围(WC)的中心性肥胖定义。
- 代谢综合征定义为以下≥3项:中心性肥胖、甘油三酯≥150 mg/dL、高密度脂蛋白胆固醇(男性<40 mg/dL,女性<50 mg/dL)、血压≥130/85 mm Hg、空腹血糖≥100 mg/dL或非空腹血糖≥140 mg/dL。
- 代谢综合征严重程度评分(MSSS)作为代谢综合征的连续测量指标。
临床怎么用
- 临床评估青光眼风险时,应区分肥胖类型:BMI或腰围增高可能不增加青光眼风险,而代谢综合征异常聚集与青光眼风险升高相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: The literature surrounding the relationship between obesity and glaucoma is conflicting. The aim of this study was to examine associations between obesity, metabolic syndrome (MetS) and glaucoma prevalence in the National Institutes of Health All of Us (AoU) research programme. METHODS: 156 362 individuals over age 40 were included in analyses. Obesity was defined by (1) body mass index (BMI) and (2) central obesity based on waist circumference (WC). MetS was defined as ≥3 of the following: central obesity (CO), triglycerides ≥150 mg/dL, high-density lipoprotein cholesterol (<40 mg/dL for men and <50 mg/dL for women), blood pressure ≥130/85 mm Hg and fasting glucose ≥100 mg/dL or non-fasting glucose ≥140 mg/dL. Metabolic Syndrome Severity Score (MSSS) was captured as a continuous measure of MetS. Logistic regression models examined associations between (1) BMI, (2) CO, (3) WC, (4) MetS, (5) MSSS and glaucoma prevalence. RESULTS: Overweight (OR 0.80 (95% CI 0.74 to 0.86)) and obese (OR 0.79 (95% CI 0.74 to 0.85)) individuals based on BMI and those with CO (OR 0.87 (95% CI 0.83 to 0.93)) and increased WC (OR 0.97 (95% CI 0.95 to 0.99)) had lower odds of glaucoma compared with non-overweight individuals. Individuals with MetS (OR 1.35 (95% CI 1.27 to 1.44)) and higher MSSS (OR 1.19 (95% CI 1.16 to 1.22)) had increased odds of glaucoma compared with individuals without MetS. CONCLUSION: In AoU, higher BMI and increased WC were associated with a lower likelihood of glaucoma, while MetS was associated with an increased likelihood of glaucoma.
引用
- Paul M, Lee J, Kitayama K, et al. Associations between obesity, metabolic syndrome and glaucoma in the National Institutes of Health 'All of Us' research programme. Br J Ophthalmol. 2026. PMID: 41605611. doi:10.1136/bjo-2025-328112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。